Influenza vaccine adverse reactions

Revision as of 14:17, 9 January 2014 by Mohamed Moubarak (talk | contribs) (Created page with "__NOTOC__ {{Influenza vaccine}} {{CMG}}; {{AE}} {{MM}} ==Adverse Reactions== The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicit...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Influenza vaccine
FLUBLOK® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Adverse Reactions

The most common (≥10%) injection-site reaction was pain (>37%); the most common (≥10%) solicited systemic adverse reactions were headache (>15%), fatigue (>15%) and myalgia (>11%).ref name="dailymed.nlm.nih.gov">"FLUBLOK (INFLUENZA VACCINE) INJECTION, SOLUTION [PROTEIN SCIENCES CORPORATION]". Text " accessdate" ignored (help)</ref>

References

Adapted from the FDA Package Insert.